All Time HighAarti Drugs has hit an all time high of Rs 264.85 on NSE
52 Week HighAarti Drugs has hit a 52wk high of Rs 262.35 on BSE
AnnouncementsAarti Drugs to consider second interim dividend
|Company Name||Last Price||%
|Dr Reddys Labs||2676.50||-0.47||2939.80||1786.50||45,529.64|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Aarti Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 323.60 crore.The company has reported a standalone sales of Rs 221.76 crore and a Net Profit of Rs 14.16 crore for the quarter ended Dec 2013.
The company management includes Chandrakant V Gogri - Chairman Emeritus, Prakash M Patil - Managing Director & CEO, Harshit M Savla - Joint Managing Director & CFO, Rajendra V Gogri - Chairman, Harit P Shah - Whole Time Director, Uday M Patil - Whole Time Director, Ramdas M Gandhi - Independent Director, Bhavesh R Vora - Independent Director, Navin C Shah - Independent Director, Vilas G Gaikar - Independent Director, Sunil M Dedhia - Independent Director, Krishnacharya G Akamanchi - Independent Director, Rashesh C Gogri - Whole Time Director.
It is listed on the BSE with a BSE Code of 524348 and the NSE with an NSE Code of AARTIDRUGS.
Its Registered office is at Plot No. N-198, MIDC, Tarapur,,Village - Pamtembhi, Thane District,Maharashtra - 401506.
Their Registrars are Sharepro Services (India) Pvt.Ltd.